PI
ALXN

PEAK6 Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

PEAK6 Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Hold
0
– – – 6408
2020
Q4 		– Sell
-8,907
Closed -$1.14M – 5864
2020
Q3 		$1.02M Buy
8,907
+4,904
+123% +$529K 0.03% 2256
2020
Q2 		$449K Sell
4,003
-72,498
-95% -$7.7M 0.02% 2773
2020
Q1 		$6.87M Buy
76,501
+68,283
+831% +$6.7M 0.34% 417
2019
Q4 		$889K Sell
8,218
-39,469
-83% -$4.22M 0.04% 1599
2019
Q3 		$4.67M Buy
47,687
+35,504
+291% +$4M 0.19% 712
2019
Q2 		$1.6M Buy
12,183
+5,799
+91% +$747K 0.07% 1460
2019
Q1 		$863K Sell
6,384
-9,252
-59% -$1.15M 0.04% 1961
2018
Q4 		$1.52M Sell
15,636
-5,015
-24% -$593K 0.07% 1433
2018
Q3 		$2.87M Buy
+20,651
New +$2.59M 0.12% 1170

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return